CHUGAI PHARMACEUTICAL
CHUGAI PHARMACEUTICAL
Share · JP3519400000 · 857216 (LSSI)
Overview
No Price
19.12.2025 17:21
Current Prices from CHUGAI PHARMACEUTICAL
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
CUP.F
EUR
19.12.2025 14:29
44,37 EUR
0,07 EUR
+0,16 %
XHAN: Hannover
Hannover
CPCLRS00.HANB
EUR
19.12.2025 07:01
44,87 EUR
0,57 EUR
+1,29 %
XDQU: Quotrix
Quotrix
CPCLRS00.DUSD
EUR
19.12.2025 06:27
45,45 EUR
1,15 EUR
+2,60 %
XDUS: Düsseldorf
Düsseldorf
CPCLRS00.DUSB
EUR
18.12.2025 18:31
44,21 EUR
-0,39 EUR
-0,87 %
XHAM: Hamburg
Hamburg
CPCLRS00.HAMB
EUR
18.12.2025 07:08
44,77 EUR
0,17 EUR
+0,38 %
XTKS: Tokyo
Tokyo
4519.T
JPY
09.12.2025 05:42
8.230,00 JPY
6,00 JPY
+0,07 %
OTC: UTC
UTC
CHGCF
USD
08.12.2025 21:00
52,45 USD
-1,20 USD
-2,24 %
Share Float & Liquidity
Free Float 38,88 %
Shares Float 639,77 M
Shares Outstanding 1,65 B
Invested Funds

The following funds have invested in CHUGAI PHARMACEUTICAL:

Fund
iShares MSCI Japan SRI UCITS ETF USD (Dist)
Vol. in million
2.158,27
Percentage (%)
2,70 %
Fund
iShares MSCI Japan SRI UCITS ETF
Vol. in million
19.953,67
Percentage (%)
2,70 %
Fund
iShares MSCI Japan SRI EUR Hedged UCITS ETF (Acc)
Vol. in million
1.651,96
Percentage (%)
2,55 %
Fund
iShares Nikkei 225® UCITS ETF (DE)
Vol. in million
360.077,30
Percentage (%)
1,63 %
Fund
iShares Refinitiv Inclusion and Diversity UCITS ETF
Vol. in million
379,76
Percentage (%)
0,97 %
Company Profile for CHUGAI PHARMACEUTICAL Share
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
AI Analysis of CHUGAI PHARMACEUTICAL
Click any analysis below to get instant AI insights from finAgent

Company Data

Name CHUGAI PHARMACEUTICAL
Company Chugai Pharmaceutical Co., Ltd.
Website https://www.chugai-pharm.co.jp
Primary Exchange LSSI Lang & Schwarz
WKN 857216
ISIN JP3519400000
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Osamu Okuda
Market Capitalization 13.645 Mrd.
Country Japan
Currency EUR
Employees 5,0 T
Address Nihonbashi Mitsui Tower, 103-8324 Tokyo
IPO Date 2000-01-04

Ticker Symbols

Name Symbol
Over The Counter CHGCF
Düsseldorf CPCLRS00.DUSB
Frankfurt CUP.F
Hamburg CPCLRS00.HAMB
Hannover CPCLRS00.HANB
Quotrix CPCLRS00.DUSD
Tokyo 4519.T
More Shares
Investors who hold CHUGAI PHARMACEUTICAL also have the following shares in their portfolio:
BASF SE
BASF SE Share
CINTAS CORP
CINTAS CORP Share
DEUTSCHE TELEKOM AG
DEUTSCHE TELEKOM AG Share
EUROFINS SCI.EO 0,01
EUROFINS SCI.EO 0,01 Share
HSBC BANK PLC NTS EUKAIROS INV LTD SRS 1282 13/03/26
HSBC BANK PLC NTS EUKAIROS INV LTD SRS 1282 13/03/26 Bond
LLOYDS BANKING GROUP PLC 2.94% NTS 24/01/28
LLOYDS BANKING GROUP PLC 2.94% NTS 24/01/28 Bond
LPKF LASER+ELECTRON.
LPKF LASER+ELECTRON. Share
NINTENDO CO LTD
NINTENDO CO LTD Share
PETROL.BRAS.PFD ADR/2 O.N
PETROL.BRAS.PFD ADR/2 O.N Share
PFEIFFER VACUUM AG
PFEIFFER VACUUM AG Share
SIXT SE VZO
SIXT SE VZO Share
TSINGTAO BREWERY  H  YC 1
TSINGTAO BREWERY H YC 1 Share
UNITED INTERNET AG
UNITED INTERNET AG Share
VARTA AG
VARTA AG Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025